Modulation by bradykinin of angiotensin type 1 receptor-evoked RhoA activation of connective tissue growth factor expression in human lung fibroblasts

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 6, 2006, Pages

  Huang, Zhenhua ^a   Taylor, Linda ^a   Liu, Bin ^a   Yu, Jun ^a   Polgar, Peter ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II receptor; Bradykinin receptor; IMR 90 fibroblasts; RhoA

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; BINDING PROTEIN; BRADYKININ B1 RECEPTOR; CONNECTIVE TISSUE GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; RHO KINASE;

ARTICLE; BIOASSAY; CELL CULTURE; CONTROLLED STUDY; EFFECTOR CELL; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANGIOTENSIN II; BRADYKININ; CELL LINE; DNA PRIMERS; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; POLYMERASE CHAIN REACTION; PROTEIN CONFORMATION; RECEPTOR, ANGIOTENSIN, TYPE 1; RHOA GTP-BINDING PROTEIN; TETRACYCLINE;

EID: 33744790264     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00443.2005     Document Type: Article

References (40)

1. Abou-Shady M, Friess H, Zimmermann A, di Mola FF, Guo XZ, Baer HU, and Buchler MW. Connective tissue growth factor in human liver cirrhosis. Liver 20: 296-304, 2000.
2. Akagi T, Shishido T, Murata K, and Hanafusa H. v-Crk activates the phosphoinositide 3-kinase/AKT pathway in transformation. Proc Natl Acad Sci USA 97: 7290-7295, 2000.
3. Allen JT, Knight RA, Bloor CA, and Spiteri MA. Enhanced insulin-like growth factor binding protein-related protein 2 (Connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol 21: 693-700, 1999.
4. Aoki H, Izumo S, and Sadoshima J. Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation. Circ Res 82: 666-676, 1998.
5. 2-adrenoreceptor-stimulated RhoA and Rho kinase in rat aorta. Am J Physiol Heart Circ Physiol 283: H1361-H1369, 2002.
6. Cui XS and Kim NH. Polyamines inhibit apoptosis in porcine parthenotes developing in vitro. Mol Reprod Dev 70: 471-477, 2005.
7. Daviet L, Lehtonen JY, Hayashida W, Dzau VJ, and Horiuchi M. Intracellular third loops in AT1 and AT2 receptors determine subtype specificity. Life Sci 69: 509-516, 2001.
8. Ehler E, Babiychuk E, and Draeger A. Human foetal lung (IMR-90) cells: myofibroblasts with smooth muscle-like contractile properties. Cell Motil Cytoskeleton 34: 288-298, 1996.
9. Finckenberg P, Inkinen K, Ahonen J, Merasto S, Louhelainen M, Vapaatalo H, Muller D, Ganten D, Luft F, and Mervaala E. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 163: 355-366, 2003.
10. Griendling KK, Lassegue B, Murphy TJ, and Alexander RW. Angiotensin II receptor pharmacology. Adv Pharmacol 28: 269-306, 1994.
11. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37: 614-636, 1965.
12. Hunyady L, Zhang M, Jagadeesh G, Bor M, Balla T, and Catt KJ. Dependence of agonist activation on a conserved apolar residue in the third intracellular loop of the AT1 angiotensin receptor. Proc Natl Acad Sci USA 93: 10040-10045, 1996.
13. Inoue Y, Nakamura N, and Inagami T. A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. J Hypertens 15: 703-714, 1997.
14. Iwanciw D, Rehm M, Porst M, and Goppelt-Struebe M. Induction of connective tissue growth factor by angiotensin II: integration of signaling pathways. Arterioscler Thromb Vasc Biol 23: 1782-1787, 2003.
15. Kaschina E and Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press 12: 70-88, 2003.
16. Kim KH, Park GT, Lim YB, Rue SW, Jung JC, Sonn JK, Bae YS, Park JW, and Lee YS. Expression of connective tissue growth factor, a biomarker in senescence of human diploid fibroblasts, is up-regulated by a transforming growth factor-beta-mediated signaling pathway. Biochem Biophys Res Commun 318: 819-825, 2004.
17. Leask A, Holmes A, Black CM, and Abraham DJ. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 278: 13008-13015, 2003.
18. 18a. Liu B, Yu J, Taylor L, Zhou X, and Polgar P. Microarray and phosphokinase screenings leading to studies on ERK and JNK regulation of connective tissue growth factor expression by angiotensin II 1a and bradykinin B2 receptors in Rat1 fibroblasts. J Cell Biochem. 97: 1104-1120, 2006.
19. Maestri R, Milia AF, Salis MB, Graiani G, Lagrasta C, Monica M, Corradi D, Emanueli C, and Madeddu P. Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice. Hypertension 41: 1151-1155, 2003.
20. Marshall RP, McAnulty RJ, and Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med 161: 1999-2004, 2000.
21. Meacci E, Nuti F, Catarzi S, Vasta V, Donati C, Bourgoin S, Bruni P, Moss J, and Vaughan M. Activation of phospholipase D by bradykinin and sphingosine 1-phosphate in A549 human lung adenocarcinoma cells via different GTP-binding proteins and protein kinase C delta signaling pathways. Biochemistry 42: 284-292, 2003.
22. Mezzano SA, Ruiz-Ortega M, and Egido J. Angiotensin II and renal fibrosis. Hypertension 38: 635-638, 2001.
23. Miura S, Saku K, and Karnik SS. Molecular analysis of the structure and function of the angiotensin II type 1 receptor. Hypertens Res 26: 937-943, 2003.
24. Moussad EE and Brigstock DR. Connective tissue growth factor: what's in a name? Mol Genet Metab 71: 276-292, 2000.
25. Nichols WW, Murphy DG, Cristofalo VJ, Toji LH, Greene AE, and Dwight SA. Characterization of a new human diploid cell strain, IMR-90. Science 196: 60-63, 1977.
26. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, Nauck M, Marz W, Rupp J, Pech M, and Luscher TF. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 95: 831-839, 1997.
27. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 54: 57-79, 2001.
28. Prado GN, Taylor L, and Polgar P. Effects of intracellular tyrosine residue mutation and carboxyl terminus truncation on signal transduction and internalization of the rat bradykinin B2 receptor. J Biol Chem 272: 14638-14642, 1997.
29. 2. Am J Physiol Lung Cell Mol Physiol 277: L1165-L1171, 1999.
30. Rishikof DC, Ricupero DA, Kuang PP, Liu H, and Goldstein RH. Interleukin-4 regulates connective tissue growth factor expression in human lung fibroblasts. J Cell Biochem 85: 496-504, 2002.
31. Schnee JM and Hsueh WA. Angiotensin II, adhesion, and cardiac fibrosis. Cardiovasc Res 46: 264-268, 2000.
32. Seta K, Nanamori M, Modrall JG, Neubig RR, and Sadoshima J. AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs. J Biol Chem 277: 9268-9277, 2002.
33. Touyz RM and Berry C. Recent advances in angiotensin II signaling. Braz J Med Biol Res 35: 1001-1015, 2002.
34. Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T, and Mori M. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol 28: 754-761, 2003.
35. Watts KL and Spiteri MA. Connective tissue growth factor expression and induction by transforming growth factor-β is abrogated by simvastatin via a Rho signaling mechanism. Am J Physiol Lung Cell Mol Physiol 287: L1323-L1332, 2004.
36. Xoriuchi M, Hamai M, Cui TX, Iwai M, and Minokoshi Y. Cross talk between angiotensin II type 1 and type 2 receptors: cellular mechanism of angiotensin type 2 receptor-mediated cell growth inhibition. Hypertens Res 22: 67-74, 1999.
37. Yu J, Liu B, Eramian D, Mierke D, Taylor L, and Polgar P. K317, R319, and E320 within the proximal C-terminus of the bradykinin B2 receptor form a motif important for phospholipase C and phospholipase A2 but not connective tissue growth factor related signaling. J Cell Biochem 92: 547-559, 2004.
38. Yu J, Prado GN, Taylor L, Pal-Ghosh R, and Polgar P. Hybrid formation between the intracellular faces of the bradykinin B2 and angiotensin II AT1 receptors and signal transduction. Int Immunopharmacol 2: 1807-1822, 2002.
39. Zhu MJ, Kim CD, Kwon YB, Kye KC, Chen YY, Lee WH, Lee S, Lim JS, Seo YJ, Suhr KB, Park JK, and Lee JH. Induction of connective tissue growth factor expression by sphingosylphosphorylcholine in cultured human skin fibroblasts. Exp Dermatol 14: 509-514, 2005.
40. Zumbihl R, Aepfelbacher M, Andor A, Jacobi CA, Ruckdeschel K, Rouot B, and Heesemann J. The cytotoxin YopT of Yersinia enterocolitica induces modification and cellular redistribution of the small GTP-binding protein RhoA. J Biol Chem 274: 29289-29293, 1999.